Details for Patent: 7,365,205
✉ Email this page to a colleague
Which drugs does patent 7,365,205 protect, and when does it expire?
Patent 7,365,205 protects SAVAYSA and is included in one NDA.
This patent has sixty patent family members in twenty-five countries.
Summary for Patent: 7,365,205
Title: | Diamine derivatives |
Abstract: | A compound represented by the general formula (1): Q.sup.1-Q.sup.2-T.sup.0-N(R.sup.1)-Q.sup.3-N(R.sup.2)-T.sup.1-Q.sup.4 (1) wherein R.sup.1 and R.sup.2 are hydrogen atoms or the like; Q.sup.1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q.sup.2 is a single bond or the like; Q.sup.3 is a group ##STR00001## in which Q.sup.5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T.sup.0 and T.sup.1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing. |
Inventor(s): | Ohta; Toshiharu (Tokyo, JP), Komoriya; Satoshi (Tokyo, JP), Yoshino; Toshiharu (Tokyo, JP), Nagamochi; Masatoshi (Tokyo, JP), Ono; Makoto (Tokyo, JP) |
Assignee: | Daiichi Sankyo Company, Limited (Tokyo, JP) |
Application Number: | 10/481,262 |
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 7,365,205
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Daiichi Sankyo Inc | SAVAYSA | edoxaban tosylate | TABLET;ORAL | 206316-001 | Jan 8, 2015 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
Daiichi Sankyo Inc | SAVAYSA | edoxaban tosylate | TABLET;ORAL | 206316-002 | Jan 8, 2015 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
Daiichi Sankyo Inc | SAVAYSA | edoxaban tosylate | TABLET;ORAL | 206316-003 | Jan 8, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,365,205
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Japan | 2001-187105 | Jun 20, 2001 |
Japan | 2001-243046 | Aug 9, 2001 |
Japan | 2001-311808 | Oct 9, 2001 |
PCT Information | |||
PCT Filed | March 20, 2002 | PCT Application Number: | PCT/JP02/02683 |
PCT Publication Date: | January 03, 2003 | PCT Publication Number: | WO03/000657 |
International Family Members for US Patent 7,365,205
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 1405852 | ⤷ Sign Up | CA 2015 00052 | Denmark | ⤷ Sign Up |
European Patent Office | 1405852 | ⤷ Sign Up | 92835 | Luxembourg | ⤷ Sign Up |
European Patent Office | 1405852 | ⤷ Sign Up | 15C0068 | France | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |